Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. And then there were three. The US Food and Drug Administration (FDA) today granted emergency use authorization (EUA) to the Ad26.COV2.S vaccine from Janssen/Johnson & Johnson (J&J) for people 18 and older after reviewing its safety and efficacy data. More vaccine
0 Comments
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older. This
0 Comments
The Food and Drug Administration has approved Johnson & Johnson‘s Covid-19 vaccine for emergency use, giving the United States a third tool to fight the pandemic as highly contagious variants start to take root across the country. The FDA’s emergency use authorization Saturday kickstarts the federal government’s plan to distribute nearly 4 million doses of
0 Comments
Serum neurofilament light (NfL), a marker of neuronal injury, was tied to multiple sclerosis (MS) disability, brain atrophy, and disease activity, a large real-world study showed. Among nearly 7,000 MS patients, those with elevated serum NfL had worse walking speed, manual dexterity, and processing speed; lower whole brain and thalamic volumes; and higher number of
0 Comments
Brian J. Gerber, Arizona State University and Melanie Gall, Arizona State University After one month in office, the Biden administration has fundamentally changed how the federal government responds to the COVID-19 pandemic. In direct contrast to his predecessor, President Joe Biden is treating this as a national-scale crisis requiring a comprehensive national strategy and federal
0 Comments
Feb. 26, 2021 — After several weeks of declining, COVID-19 numbers are back on the rise and new variants continue to emerge, according to White House officials — just as states begin to lift restrictions and open doors to restaurants and businesses. CDC Director Rochelle Walensky, MD, reported during a Friday COVID-19 briefing that coronavirus cases and
0 Comments
On Wednesday, the FDA announced that the Johnson and Johnson coronavirus vaccine was safe, more effective on serious cases of Covid-19 than on more moderate cases, and totally protective against hospitalizations and death.  Today, the independent group of infectious disease professionals that advises the FDA on whether a vaccine should receive a thumb’s up or
0 Comments
Adrienne Herbert, host of the acclaimed podcast ‘Power Hour’ and now author of a book of the same name, shares the simple change to your routine that could transform your whole day. Adrienne’s voice is so familiar to me that when we first speak I have to remind myself that we haven’t actually met before.
0 Comments
An FDA advisory panel lent their support today to a rapid clearance for Janssen/Johnson & Johnson’s COVID-19 vaccine. The Food and Drug Administration (FDA) is expected to quickly provide an emergency use authorization (EUA) for the vaccine following the recommendation by the panel. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 22-0 on
0 Comments
While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery. Now, research from the Children’s Medical Center Research Institute at UT Southwestern (CRI) has identified the cells responsible for liver maintenance and regeneration while also pinpointing where they
0 Comments
A majority of women with uncomplicated urinary tract infections (UTIs) received inappropriate antibiotics or continued treatment beyond the recommended duration, a review of almost 700,000 cases showed. Overall, 46.7% of patients received prescriptions for inappropriate antibiotics and 76.1% had inappropriately long duration of treatment. The frequency of inappropriate antibiotic agents was similar between urban and
0 Comments
Every year on the last day of February, the world recognizes rare diseases—a day now known as Rare Disease Day. Rare diseases affect approximately 25 million to 30 million people in the United States each year. The purpose of Rare Disease Day is to educate the public and raise awareness among decision-makers about the impact of
0 Comments
by Sarah Kwon This story also ran on NBC News. For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19
0 Comments
In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout. “I said ‘Oh, my God!’ ” she recalled. “Super loud. My kids jumped up. My husband looked over. He said, ‘What’s wrong, what’s wrong, is everything OK?’ I was like, ‘No, no, it’s
0 Comments
Oftentimes, I find myself standing in front of the pantry looking for something small and healthy that I could take on the go. As someone living with type 1 diabetes, “grabbing something” takes more thought than you’d like, as you want this snack to be kind to your blood sugars…and your waistline. Since NRG bites
0 Comments
Satjit Bhusri, MD, is worried about heart health, his own, and yours. A long-time New York City cardiologist, he is now treating the aftereffects of Covid-19. “What’s unusual about COVID…is that it is extremely inflammatory. That means the body attacks [the virus], and [the immune system] kind of goes overboard,” he said. What is unnerving
0 Comments
22 February 2021 — AstraZeneca today announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer. This decision was made in consultation with the Food and Drug Administration (FDA). In May 2017, Imfinzi was granted accelerated approval in the US based on promising
0 Comments
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45 CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) —  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Amondys
0 Comments
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta. Tami Chappell | Reuters A new CDC study found that some elderly who apparently recovered from the coronavirus later came down with a second, even worse infection — indicating that asymptomatic or mild cases may not provide a lot of
0 Comments
Ahead of Rare Disease Day (28 February), four leading children’s research institutions on three continents are joining forces to decipher pediatric illnesses, including rare diseases, and find better treatments. The four pediatric hospitals — Boston Children’s Hospital; UCL Great Ormond Street Institute for Child Health and Great Ormond Street Hospital (London); the Murdoch Children’s Research
0 Comments